ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 890,18
0,76%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aptose Biosciences Inc (APTO)

  7. Aptose Biosciences Inc (APTO) Actualités

APTO Aptose Biosciences Inc

1,22
0,06 (5,17%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Aptose Biosciences Inc APTO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,06 5,17% 1,22 06:00:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,21 1,16 1,27 1,22 1,16
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/3/202423:00EDGAR2Form 8-K - Current report
14/2/202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:02EDGAR2Form 8-K - Current report
26/1/202423:30EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
26/1/202414:00EDGAR2Form 8-K - Current report
26/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/1/202403:44EDGAR2Form S-1MEF - Registration adding securities to prior Form..
20/1/202403:50EDGAR2Form S-1/A - General form for registration of securities..
29/12/202322:10EDGAR2Form S-1/A - General form for registration of securities..
11/12/202312:30EDGAR2Form 8-K - Current report
11/12/202312:15EDGAR2Form S-1/A - General form for registration of securities..
30/11/202323:28EDGAR2Form 8-K - Current report
09/11/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202314:15EDGAR2Form 8-K - Current report
30/10/202314:20EDGAR2Form 8-K - Current report
26/10/202316:12EDGAR2Form 8-K - Current report
23/10/202314:00EDGAR2Form 8-K - Current report
16/10/202314:00EDGAR2Form 8-K - Current report
25/9/202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202323:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/9/202314:00EDGAR2Form 8-K - Current report
12/9/202322:30EDGAR2Form 8-K - Current report
06/9/202314:01EDGAR2Form 8-K - Current report
24/8/202314:00EDGAR2Form 8-K - Current report
10/8/202322:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:10EDGAR2Form 8-K - Current report
06/7/202322:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/6/202322:15EDGAR2Form S-1/A - General form for registration of securities..

Dernières Valeurs Consultées

NASDAQ
APTO
Aptose Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés